The CMS listed Ozempic, Rybelsus and Wegovy — all forms of semaglutide — at the top of the list of drugs for which Medicare will the negotiate the price of in 2025. The list price for a one ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in Medicare.

The Centers for Medicare and Medicaid Services is moving forward with Medicare drug price negotiations under the Trump administration, although it said it is seeking to bring "greater transparency ...

released the second list of prescription medications covered under Medicare Part D. The list has 15 drugs, touted as an effort to help lower the financial burden for millions of patients who are ...

Teva's lawsuit was filed on Jan. 15, two days before the company's Austedo/Austedo XR (deutetrabenazine) was included in CMS' latest list of drugs subject to price negotiation.